Industry Urges Korean Govt To Provide More Support To CROs
This article was originally published in PharmAsia News
Executive Summary
Although South Korea's contract research organization (CRO) sector has grown and developed on the back of more robust R&D investments by the pharma industry, a recent report has suggested that the government should provide more systematic support to foster domestic CROs, which still lack global competitiveness due to a lack of experience.